ArticleCancers2022

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.

Michael Leisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.